WHO’s First Emergency Mpox Test Approved, Boosting Global Health Response
WHO has approved the first emergency mpox diagnostic test, enhancing global efforts to detect and manage outbreaks.
My Global News: Voices of a New Era
๐ Stay Ahead, Stay Global ๐
WHO has approved the first emergency mpox diagnostic test, enhancing global efforts to detect and manage outbreaks.
Bayer’s EVP Juergen Eckhardt highlights the impact of Chinese mainland innovation on global healthcare, emphasizing the company’s commitment to serving patients worldwide.
The World Health Organization (WHO) has approved the MVA-BN vaccine as the first mpox vaccine on its prequalification list, enhancing global access and outbreak control efforts.
Africa faces a $224 million funding gap to combat the mpox outbreak, with only $20 million secured so far. Africa CDC seeks urgent support to procure vaccines and resources.
Zanzibari President honors Chinese medical team for their year-long service, treating 40,000 patients and advancing local healthcare.
Thailand reports its second mpox case of the clade 1b variant outside Africa, raising global health concerns and prompting vigilant contact tracing.
WHO declares mpox a public health emergency, highlighting rising cases and the risk of further spread. The EU and biotech firms are responding with vaccine donations.
New research shows long COVID-19 has affected 400 million globally, costing $1 trillion each year, and highlights urgent policy and treatment needs.
Traditional Chinese Medicine (TCM) gains global recognition. Learn how experts advocate for integrating TCM with Western medicine to enhance healthcare outcomes.
The Chinese mainland has launched a 3-year initiative to standardize Traditional Chinese Medicine, integrating AI and promoting global cooperation to enhance safety and efficacy.